62 related articles for article (PubMed ID: 12899660)
21. The design and synthesis of purine inhibitors of CDK2. III.
Shum PW; Peet NP; Weintraub PM; Le TB; Zhao Z; Barbone F; Cashman B; Tsay J; Dwyer S; Loos PC; Powers EA; Kropp K; Wright PS; Bitonti A; Dumont J; Borcherding DR
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1067-78. PubMed ID: 11562960
[TBL] [Abstract][Full Text] [Related]
22. A new, unexpected action of olomoucine, a CDK inhibitor, on normal human cells: up-regulation of CLIMP-63, a cytoskeleton-linking membrane protein.
Wesierska-Gadek J; Gueorguieva M; Kramer MP; Ranftler C; Sarg B; Lindner H
J Cell Biochem; 2007 Dec; 102(6):1405-19. PubMed ID: 17975794
[TBL] [Abstract][Full Text] [Related]
23. In vitro metabolism of the analgesic bicifadine in the mouse, rat, monkey, and human.
Erickson DA; Hollfelder S; Tenge J; Gohdes M; Burkhardt JJ; Krieter PA
Drug Metab Dispos; 2007 Dec; 35(12):2232-41. PubMed ID: 17881661
[TBL] [Abstract][Full Text] [Related]
24. Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs.
Ribas J; Boix J
Exp Cell Res; 2004 Apr; 295(1):9-24. PubMed ID: 15051486
[TBL] [Abstract][Full Text] [Related]
25. Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine.
Buraei Z; Anghelescu M; Elmslie KS
Biophys J; 2005 Sep; 89(3):1681-91. PubMed ID: 15951378
[TBL] [Abstract][Full Text] [Related]
26. Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine.
Schulze-Gahmen U; Brandsen J; Jones HD; Morgan DO; Meijer L; Vesely J; Kim SH
Proteins; 1995 Aug; 22(4):378-91. PubMed ID: 7479711
[TBL] [Abstract][Full Text] [Related]
27. In vitro metabolism and covalent binding of ethylbenzene to microsomal protein as a possible mechanism of ethylbenzene-induced mouse lung tumorigenesis.
Saghir SA; Zhang F; Rick DL; Kan L; Bus JS; Bartels MJ
Regul Toxicol Pharmacol; 2010; 57(2-3):129-35. PubMed ID: 20096743
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases.
Vermeulen K; Strnad M; Krystof V; Havlícek L; Van der Aa A; Lenjou M; Nijs G; Rodrigus I; Stockman B; van Onckelen H; Van Bockstaele DR; Berneman ZN
Leukemia; 2002 Mar; 16(3):299-305. PubMed ID: 11896531
[TBL] [Abstract][Full Text] [Related]
29. [Effects of cyclin dependent protein kinase inhibitor olomoucine on the microenvironment of axonal regeneration after spinal cord injury: an experiment with rats].
Tian DS; Wang W; Xu YL; Yu ZY; Xie MJ; Wang P; Zhang GB
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):901-5. PubMed ID: 16759516
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors.
Chang YT; Gray NS; Rosania GR; Sutherlin DP; Kwon S; Norman TC; Sarohia R; Leost M; Meijer L; Schultz PG
Chem Biol; 1999 Jun; 6(6):361-75. PubMed ID: 10375538
[TBL] [Abstract][Full Text] [Related]
31. Caspase 8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibitory drugs.
Ribas J; Gomez-Arbones X; Boix J
Eur J Pharmacol; 2005 Nov; 524(1-3):49-52. PubMed ID: 16243312
[TBL] [Abstract][Full Text] [Related]
32. The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.
Holcakova J; Tomasec P; Bugert JJ; Wang EC; Wilkinson GW; Hrstka R; Krystof V; Strnad M; Vojtesek B
Antivir Chem Chemother; 2010 Jan; 20(3):133-42. PubMed ID: 20054100
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey.
Johnson BM; Kamath AV; Leet JE; Liu X; Bhide RS; Tejwani RW; Zhang Y; Qian L; Wei DD; Lombardo LJ; Shu YZ
Drug Metab Dispos; 2008 Dec; 36(12):2475-83. PubMed ID: 18787055
[TBL] [Abstract][Full Text] [Related]
34. In vitro metabolism of irosustat, a novel steroid sulfatase inhibitor: interspecies comparison, metabolite identification, and metabolic enzyme identification.
Ventura V; Solà J; Celma C; Peraire C; Obach R
Drug Metab Dispos; 2011 Jul; 39(7):1235-46. PubMed ID: 21464173
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of aildenafil in vivo in rats and in vitro in mouse, rat, dog, and human liver microsomes.
Li Y; Wu L; Gu Y; Si D; Liu C
Drug Test Anal; 2014 Jun; 6(6):552-62. PubMed ID: 24311535
[TBL] [Abstract][Full Text] [Related]
36. 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A.
Dietrich C; Faust D; Budt S; Moskwa M; Kunz A; Bock KW; Oesch F
Toxicol Appl Pharmacol; 2002 Sep; 183(2):117-26. PubMed ID: 12387751
[TBL] [Abstract][Full Text] [Related]
37. Activation of bovine oocytes by specific inhibition of cyclin-dependent kinases.
Alberio R; Kubelka M; Zakhartchenko V; Hajdúch M; Wolf E; Motlik J
Mol Reprod Dev; 2000 Apr; 55(4):422-32. PubMed ID: 10694750
[TBL] [Abstract][Full Text] [Related]
38. Glycosidation of an endothelin ET(A) receptor antagonist and diclofenac in human liver microsomes: aglycone-dependent UDP-sugar selectivity.
Tang C; Ma B
Drug Metab Dispos; 2005 Dec; 33(12):1796-802. PubMed ID: 16129696
[TBL] [Abstract][Full Text] [Related]
39. Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor.
Berry LM; Liu J; Colletti A; Krolikowski P; Zhao Z; Teffera Y
Drug Metab Dispos; 2014 Apr; 42(4):707-17. PubMed ID: 24423753
[TBL] [Abstract][Full Text] [Related]
40. In vitro glucuronidation of the cyclin-dependent kinase inhibitor flavopiridol by rat and human liver microsomes: involvement of UDP-glucuronosyltransferases 1A1 and 1A9.
Hagenauer B; Salamon A; Thalhammer T; Kunert O; Haslinger E; Klingler P; Senderowicz AM; Sausville EA; Jäger W
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):407-14. PubMed ID: 11259324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
